What Price Ecological restoration?

FEATURERestoring Natural Capital In putting a price tag on endangered species and degraded ecosystems, ecologists and economists have joined forces to formulate a new rationale for environmental issues: restoring natural capital© Erich Schlegel/Dallas Morning News/CorbisBY PADDY WOODWORTHEcological restoration is expensive. The United States government is slated to spend almost $8 billion restoring parts of the Florida Evergla

Written byPaddy Woodworth
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Ecological restoration is expensive. The United States government is slated to spend almost $8 billion restoring parts of the Florida Everglades as wetlands between 2000 and 2030. The Army Corps of Engineers had a plan to spend $14 billion to restore New Orleans' barrier islands before Hurricane Katrina arrived. On a smaller scale, South Africa, whose gross domestic product (GDP) is 4% that of the United States, is spending $450 million to restore native vegetation and increase water supply.

Can countries afford to spend such sums on ecological restoration? A new school of economists and ecologists answers with another question: Can the world's economies afford not to? Consider New Orleans: Ecological engineer William J. Mitsch1 claims that restoring Louisiana's wetlands would have saved a massive bill for rebuilding New Orleans. The $14 billion cost of restoring barrier islands pales in comparison to the $100 billion it is now thought reconstructing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies